Stem Cells

  • Patients blinded by treatment touted as ‘trial’

    After three patients were blinded following a treatment marketed as a stem cell clinical trial, Stanford ophthalmologist Jeffrey Goldberg calls for increased patient education and regulation.

  • Scientists awarded stem cell grants

    The grants to Stanford researchers target stem cell-based therapies for autoimmune disorders, liver disease and cystic fibrosis.

  • Rat-grown pancreases help save diabetic mice

    Growing organs from one species in the body of another may one day relieve transplant shortages. Now researchers show that islets from rat-grown mouse pancreases can reverse disease when transplanted into diabetic mice.

  • Fewer bone stem cells in diabetes impedes healing

    Stanford researchers found that activating bone stem cells helps repair fractures in diabetic mice. Applying a protein to the fracture site increased the expression of key signaling proteins and enhanced healing in the animals.

  • Samuel Strober awarded $6.6 million

    The California Institute for Regenerative Medicine awarded Samuel Strober, MD, $6.6 million to study a “deceptively simple” way to help kidney transplant recipients tolerate their new organ.

  • Stem cells police themselves to reduce scarring

    Stem cells produce a decoy protein to attenuate growth signals. Artificially regulating this pathway might help keep muscles supple in muscular dystrophy or during normal aging, researchers hope.

  • Canine cancer immunotherapy

    The work extends research by Stanford scientists who found that blocking CD47 might be useful in treating human cancer.

  • Paving the way for gene therapy

    Using the CRISPR gene-editing technique in stem cells, Stanford researchers repaired the gene that causes sickle cell disease, and the mended stem cells were successfully transplanted into mice.

  • Fat cell-maturation hormone found

    Mature fat cells produce a hormone that regulates the differentiation of nearby stem cells in response to glucocorticoid hormones and high-fat diets, Stanford researchers have found.

  • Dietary approach to depleting stem cells

    A new study shows that a diet deficient in valine effectively depleted the blood stem cells in mice and made it possible to perform a blood stem cell transplantation on them.

  • Cell, gene medicine lab opens

    Making cell- or virus-based therapies for use in humans requires a rigid set of quality-control standards outlined by the Food and Drug Administration. A new Stanford facility will allow promising new therapies to be tested in the clinic.


Related Websites